Collegium Pharmaceutical, Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC COLL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

53,492

Value ($000)

2,477

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,477	0.0%	53,492	12/31/2025
2025 Q3	11/14/2025	1,995	0.0%	57,016	9/30/2025
2025 Q2	8/14/2025	2,803	0.0%	94,787	6/30/2025
2025 Q1	5/19/2025	2,120	0.0%	71,014	3/31/2025
2024 Q4	2/14/2025	1,902	0.0%	66,389	12/31/2024
2024 Q3	11/14/2024	2,292	0.0%	59,326	9/30/2024
2024 Q2	8/14/2024	2,232	0.0%	69,310	6/30/2024
2024 Q1	5/15/2024	1,193	0.0%	30,729	3/31/2024
2023 Q4	2/14/2024	946	0.0%	30,729	12/31/2023
2023 Q3	11/13/2023	687	0.0%	30,729	9/30/2023
2023 Q2	8/11/2023	737	0.0%	30,729	6/30/2023
2023 Q1	5/15/2023	737	0.0%	30,729	3/31/2023
2022 Q4	2/14/2023	850	0.0%	36,656	12/31/2022
2022 Q3	11/14/2022	476	0.0%	29,717	9/30/2022
2022 Q2	8/12/2022	499	0.0%	28,159	6/30/2022
2022 Q1	5/16/2022	585	0.0%	28,715	3/31/2022
2021 Q4	2/14/2022	536	0.0%	28,715	12/31/2021
2021 Q3	11/15/2021	567	0.0%	28,715	9/30/2021
2021 Q2	8/16/2021	679	0.0%	28,715	6/30/2021
2021 Q1	5/14/2021	674	0.0%	28,424	3/31/2021
2020 Q4	3/1/2021	610	0.0%	30,434	12/31/2020
2020 Q3	11/13/2020	575	0.0%	27,612	9/30/2020
2020 Q2	8/14/2020	491	0.0%	28,072	6/30/2020
2020 Q1	5/15/2020	4,126	0.0%	252,690	3/31/2020
2019 Q4	2/14/2020	6,006	0.0%	291,829	12/31/2019